Related Experiment Video
Updated: Jul 15, 2025

Intratracheal Instillation of Stem Cells in Term Neonatal Rats
Published on: May 4, 2020
Genetics of bronchopulmonary dysplasia: An update
Pascal M Lavoie1, Jonathan H Rayment2
1Division of Neonatology, Department of Pediatrics, University of British Columbia, Vancouver, Canada; BC Children's Hospital Research Institute, Vancouver, Canada.
Insights
Bronchopulmonary dysplasia (BPD) has genetic links, with common variants and rare mutations in genes like ABCA3 influencing susceptibility and disease course in preterm infants.
Area of Science:
- Neonatal Medicine
- Genetics
- Pulmonology
Background:
- Bronchopulmonary dysplasia (BPD) is a complex lung disease in preterm infants, influenced by factors like lung immaturity, ventilation, and oxidative stress.
- Genetic predisposition to BPD is suggested by twin studies, with emerging evidence linking common genetic variants to disease risk.
- Rare mutations in genes crucial for surfactant production, such as ABCA3, SFTPB, and SFTPC, can cause severe neonatal lung disease and may impact BPD.
Purpose of the Study:
- To review the current understanding of the genetic factors contributing to bronchopulmonary dysplasia.
- To explore the role of both common genetic variants and rare mutations in BPD etiology and severity.
Main Methods:
- Review of existing literature on the genetics of BPD.
- Analysis of findings from twin studies, genetic association studies, and genomic research.
- Examination of the impact of specific gene mutations (ABCA3, SFTPB, SFTPC) on neonatal lung disease.
Main Results:
- Genetic susceptibility plays a significant role in BPD development.
- Common genetic variants are associated with BPD in preterm populations.
- Rare mutations in surfactant-related genes can lead to severe neonatal lung conditions, potentially influencing BPD.
Conclusions:
- Genetics is a key determinant in BPD, alongside clinical factors.
- Further research into genetic variants and pathways is crucial for understanding and managing BPD.
- Identifying genetic predispositions may offer new avenues for BPD prevention and treatment.
Abstract:
Bronchopulmonary dysplasia (BPD) is a multi-factorial disease that results from multiple clinical factors, including lung immaturity, mechanical ventilation, oxidative stress, pulmonary congestion due to increasing cardiac blood shunting, nutritional and immunological factors. Twin studies have indicated that susceptibility to BPD can be strongly inherited in some settings. Studies have reported associations between common genetic variants and BPD in preterm infants. Recent genomic studies have highlighted a potential role for molecular pathways involved in inflammation and lung development in affected infants. Rare mutations in genes encoding the lipid transporter ATP-binding cassette, sub-family A, member 3 (ABCA3 gene) which is involved in surfactant synthesis in alveolar type II cells, as well as surfactant protein B (SFTPB) and C (SFTPC) can also result in severe form of neonatal-onset interstitial lung diseases and may also potentially affect the course of BPD. This chapter summarizes the current state of knowledge on the genetics of BPD.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Chronic Obstructive Pulmonary Disease-I: Introduction
Pulmonary Cycle: Exhalation
Incomplete Dominance
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

